Abstract

The present invention relates to the use of a 2,5-dihydroxybenzene derivative represented by Formula (I) or a pharmaceutically acceptable salt, solvate, isomer, or prodrug thereof for the therapeutic and/or prophylactic treatment of, inter alia, actinic keratosis.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: May 7, 2013
  • Application: Nov 15, 2010
    US US 94674210 A
  • Priority: Nov 15, 2010
    US US 94674210 A
  • Priority: Aug 7, 2008
    US US 58816608 A
  • Priority: Aug 15, 2007
    US US 83950807 A
  • Priority: Jul 2, 2007
    ES ES 200701857 A
  • Priority: Aug 16, 2006
    ES ES 200602219 A
  • Priority: Aug 16, 2006
    US US 50646906 A
  • Priority: Feb 16, 2005
    ES ES 2005070017 W
  • Priority: Feb 17, 2004
    ES ES 200400371 A

Sign in to the Lens